Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 24, 2020, titled "The Company and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF.".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 24, 2020, titled "The Company and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF.".